Detalles de la búsqueda
1.
Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.
Gynecol Oncol
; 142(3): 465-70, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184721
2.
Effect of lipegfilgrastim administration as prophylaxis of chemotherapy-induced neutropenia on dose modification and incidence of neutropenic events: real-world evidence from a non-interventional study in Belgium and Luxembourg.
Acta Clin Belg
; 76(1): 10-15, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31399016
3.
MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum.
J Clin Oncol
; 38(32): 3753-3762, 2020 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32822286
4.
ENGOT-ov-6/TRINOVA-2: Randomised, double-blind, phase 3 study of pegylated liposomal doxorubicin plus trebananib or placebo in women with recurrent partially platinum-sensitive or resistant ovarian cancer.
Eur J Cancer
; 70: 111-121, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914241
Resultados
1 -
4
de 4
1
Próxima >
>>